Peripheral vestibular disorders

Current Opinion in Neurology

Volumn 26, Issue 1, 2013, Pages 81-89

  Strupp, Michael ^a   Brandt, Thomas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

benign paroxysmal positioning vertigo; bilateral vestibulopathy; Meni re's disease; vestibular neuritis; vestibular paroxysmia

Indexed keywords

BETAHISTINE; DEXAMETHASONE; GENTAMICIN; METHYLPREDNISOLONE; VALACICLOVIR;

BENIGN PAROXYSMAL POSITIONAL VERTIGO; BILATERAL VESTIBULOPATHY; CENTRAL VESTIBULAR VERTIGO; DRUG DOSE INCREASE; HERPES SIMPLEX VIRUS 1; HUMAN; MENIERE DISEASE; MIGRAINE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERILYMPH FISTULA; PHYSIOTHERAPY; POSITIONAL VERTIGO; PSYCHOGENIC VERTIGO; REVIEW; SENSORY DYSFUNCTION; SOMATOFORM PHOBIC POSTURAL VERTIGO; VERTIGO; VESTIBULAR DISORDER; VESTIBULAR EVOKED MYOGENIC POTENTIAL; VESTIBULAR MIGRAINE; VESTIBULAR NEURONITIS; VESTIBULAR PAROXYSMIA; VESTIBULOOCULAR REFLEX; VIRUS REACTIVATION; VISUAL ACUITY;

HUMANS; VESTIBULAR DISEASES; VESTIBULAR EVOKED MYOGENIC POTENTIALS; VESTIBULAR NERVE;

EID: 84872952040     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0b013e32835c5fd4     Document Type: Review

References (96)

1. Brandt T, Dieterich M, Strupp M. Vertigo and dizziness-common complaints. 2nd ed. London: Springer; 2013.
2. Bisdorff A, von Brevern M, Lempert T, Newman-Toker DE. Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res 2009; 19:1-13.
3. Brandt T, Schautzer F, Hamilton D, et al. Vestibular loss causes hippocampal atrophy and impaired spatial memory in humans. Brain 2005; 128:2732-2741.
4. Zheng Y, Balabhadrapatruni S, Baek JH, et al. The effects of bilateral vestibular loss on hippocampal volume, neuronal number, and cell proliferation in rats. Front Neurol 2012; 3:20.
5. Guinand N, Boselie F, Guyot JP, Kingma H. Quality of life of patients with bilateral vestibulopathy. Ann Otol Rhinol Laryngol 2012; 121:471-477.
6. Kim S, Oh YM, Koo JW, Kim JS. Bilateral vestibulopathy: clinical characteristics and diagnostic criteria. Otol Neurotol 2011; 32:812-817.
7. Vital D, Hegemann SC, Straumann D, et al.A new dynamic visual acuity test to assess peripheral vestibular function. Arch Otolaryngol Head Neck Surg 2010; 136:686-691.
8. Guinand N, Pijnenburg M, Janssen M, Kingma H. Visual acuity while walking and oscillopsia severity in healthy subjects and patients with unilateral and bilateral vestibular function loss. Arch Otolaryngol Head Neck Surg 2012; 138:301-306.
9. Fujimoto C, Murofushi T, Chihara Y, et al. Novel subtype of idiopathic bilateral vestibulopathy: bilateral absence of vestibular evoked myogenic potentials in the presence of normal caloric responses. J Neurol 2009; 256:1488-1492.
10. Szmulewicz DJ, Waterston JA, Halmagyi GM, et al. Sensory neuropathy as part of the cerebellar ataxia neuropathy vestibular areflexia syndrome. Neurology 2011; 76:1903-1910.
11. Kirchner H, Kremmyda O, Hufner K, et al. Clinical, electrophysiological, and MRI findings in patients with cerebellar ataxia and a bilaterally pathological head-impulse test. Ann N Y Acad Sci 2011; 1233:127-138.
12. McCall AA, Yates BJ. Compensation following bilateral vestibular damage. Front Neurol 2011; 2:88.
13. Hillier SL, McDonnell M. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev 2011; 2:CD005397.
14. Merfeld DM, Lewis RF. Replacing semicircular canal function with a vestibular implant. Curr Opin Otolaryngol Head Neck Surg 2012; 20:386-392.
15. Van de Berg R, Guinand N, Guyot JP, et al. The modified ampullar approach for vestibular implant surgery: feasibility and its first application in a human with a long-term vestibular loss. Front Neurol 2012; 3:18.
16. Cnyrim CD, Newman-Toker D, Karch C, et al. Bedside differentiation of vestibular neuritis from central 'vestibular pseudoneuritis'. J Neurol Neurosurg Psychiatry 2008; 79:458-460.
17. Kattah JC, Talkad AV, Wang DZ, et al. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke 2009; 40:3504-3510.
18. Newman-Toker DE, Kattah JC, Alvernia JE, Wang DZ. Normal head impulse test differentiates acute cerebellar strokes from vestibular neuritis. Neurology 2008; 70:2378-2385.
19. Chen L, Lee W, Chambers BR, Dewey HM. Diagnostic accuracy of acute vestibular syndrome at the bedside in a stroke unit. J Neurol 2011; 258:855-861.
20. Kim HA, Lee H. Recent advances in central acute vestibular syndrome of a vascular cause. J Neurol Sci 2012; 321:17-22.
21. + T cells. J Med Virol 2010; 82:1917-1920.
22. Roehm PC, Camarena V, Nayak S, et al. Cultured vestibular ganglion neurons demonstrate latent HSV1 reactivation. Laryngoscope 2011; 121:2268-2275.
23. Esaki S, Goshima F, Kimura H, et al. Auditory and vestibular defects induced by experimental labyrinthitis following herpes simplex virus in mice. Acta Otolaryngol 2011; 131:684-691.
24. Aw ST, Fetter M, Cremer PD, et al. Individual semicircular canal function in superior and inferior vestibular neuritis. Neurology 2001; 57:768-774.
25. Govender S, Colebatch JG. Ocular vestibular evoked myogenic potential (oVEMP) responses in acute vestibular neuritis. Clin Neurophysiol 2012; 123:1054-1055.
26. Shin BS, Oh SY, Kim JS, et al. Cervical and ocular vestibular-evoked myogenic potentials in acute vestibular neuritis. Clin Neurophysiol 2011.
27. Lin CM, Young YH. Identifying the affected branches of vestibular nerve in vestibular neuritis. Acta Otolaryngol 2011; 131:921-928.
28. Gianoli G, Goebel J, Mowry S, Poomipannit P. Anatomic differences in the lateral vestibular nerve channels and their implications in vestibular neuritis. Otol Neurotol 2005; 26:489-494.
29. Chihara Y, Iwasaki S, Murofushi T, et al. Clinical characteristics of inferior vestibular neuritis. Acta Otolaryngol 2012; 132:1288-1294.
30. Kim JS, Kim HJ. Inferior vestibular neuritis. J Neurol 2012; 259:1553-1560.
31. Brandt T, Huppert T, Hufner K, et al. Long-term course and relapses of vestibular and balance disorders. Restor Neurol Neurosci 2010; 28:69-82.
32. Huppert D, Strupp M, Theil D, et al. Low recurrence rate of vestibular neuritis: a long-term follow-up. Neurology 2006; 67:1870-1871.
33. Kim YH, Kim KS, Kim KJ, et al. Recurrence of vertigo in patients with vestibular neuritis. Acta Otolaryngol 2011; 131:1172-1177.
34. Mandala M, Santoro GP, Awrey J, Nuti D. Vestibular neuritis: recurrence and incidence of secondary benign paroxysmal positional vertigo. Acta Otolar-yngol 2010; 130:565-567.
35. Brandt T. Phobic postural vertigo. Neurology 1996; 46:1515-1519.
36. Strupp M, Zingler VC, Arbusow V, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 2004; 351:354-361.
37. Karlberg ML, Magnusson M. Treatment of acute vestibular neuronitis with glucocorticoids. Otol Neurotol 2011; 32:1140-1143.
38. Goudakos JK, Markou KD, Franco-Vidal V, et al. Corticosteroids in the treatment of vestibular neuritis: a systematic review and meta-analysis. Otol Neurotol 2010; 31:183-189.
39. Fishman JM, Burgess C, Waddell A. Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis). Cochrane Database Syst Rev 2011; CD008607.
40. Wegner I, van Benthem PP, Aarts MC, et al. Insufficient evidence for the effect of corticosteroid treatment on recovery of vestibular beuritis. Otolaryngol Head Neck Surg 2012; 147:826-831.
41. Von-Brevern M, Bertholon P, Fife T, et al. Benign paroxysmal positional vertigo-diagnostic criteria. J Vestib Res (in press).
42. Kim HA, Yi HA, Lee H. Apogeotropic central positional nystagmus as a sole sign of nodular infarction. Neurol Sci 2012; 33:1189-1191.
43. Radtke A, von Brevern M, Neuhauser H, et al. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology 2012; 79:1607-1614.
44. Fife TD, Iverson DJ, Lempert T, et al. Practice parameter: therapies for benign paroxysmal positional vertigo (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2008; 70:2067-2074.
45. Yacovino DA, Hain TC, Gualtieri F. New therapeutic maneuver for anterior canal benign paroxysmal positional vertigo. J Neurol 2009; 256:1851-1855.
46. Vannucchi P, Pecci R. Pathophysiology of lateral semicircular canal paroxysmal positional vertigo. J Vestib Res 2010; 20:433-438.
47. Kim JS, Oh SY, Lee SH, et al. Randomized clinical trial for geotropic horizontal canal benign paroxysmal positional vertigo. Neurology 2012; 79:700-707.
48. Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Meniere's disease. Laryngoscope 2007; 117:415-420.
49. Fiorino F, Pizzini FB, Beltramello A, et al. Reliability of magnetic resonance imaging performed after intratympanic administration of gadolinium in the identification of endolymphatic hydrops in patients with Meniere's disease. Otol Neurotol 2011; 32:472-477.
50. Nakashima T, Naganawa S, Teranishi M, et al. Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Meniere's disease. Acta Otolaryngol 2010; 130:338-343.
51. Tanigawa T, Tamaki T, Yamamuro O, et al. Visualization of endolymphatic hydrops after administration of a standard dose of an intravenous gadolinium-based contrast agent. Acta Otolaryngol 2011; 131:596-601.
52. Gurkov R, Flatz W, Louza J, et al. In vivo visualization of endolymphatic hydrops in patients with Meniere's disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol 2011; 268:1743-1748.
53. Katayama N, Yamamoto M, Teranishi M, et al. Relationship between endo-lymphatic hydrops and vestibular-evoked myogenic potential. Acta Otolar-yngol 2010; 130:917-923.
54. Fiorino F, Pizzini FB, Beltramello A, Barbieri F. MRI performed after intratym-panic gadolinium administration in patients with Meniere's disease: correlation with symptoms and signs. Eur Arch Otorhinolaryngol 2011; 268:181-187.
55. Grieve SM, Obholzer R, Malitz N, et al. Imaging of endolymphatic hydrops in Meniere's disease at 1.5 T using phase-sensitive inversion recovery: (1) demonstration of feasibility and (2) overcoming the limitations of variable gadolinium absorption. Eur J Radiol 2012; 81:331-338.
56. Claes G, Van den Hauwe L, Wuyts F, Van de Heyning P. Does intratympanic gadolinium injection predict efficacy of gentamicin partial chemolabyrinthect- omy in Meniere's disease patients? Eur Arch Otorhinolaryngol 2012; 269:413-418.
57. Gurkov R, Flatz W, Keeser D, et al. Effect of standard-dose betahistine on endolymphatic hydrops: an MRI pilot study. Eur Arch Otorhinolaryngol 2012 [Epub ahead of print].
58. Pullens B, Giard JL, Verschuur HP, van Benthem PP. Surgery for Meniere's disease. Cochrane Database Syst Rev 2010; CD005395.
59. Thirlwall AS, Kundu S. Diuretics for Meniere's disease or syndrome. Cochrane Database Syst Rev 2006; 3:CD003599.
60. Strupp M, Thurtell MJ, Shaikh AG, et al. Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol 2011; 258:1207-1222.
61. Stokroos R, Kingma H. Selective vestibular ablation by intratympanic genta-micin in patients with unilateral active Meniere's disease: a prospective, double-blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol 2004; 124:172-175.
62. Postema RJ, Kingma CM, Wit HP, et al. Intratympanic gentamicin therapy for control of vertigo in unilateral Meniere's disease: a prospective, double-blind, randomized, placebo-controlled trial. Acta Otolaryngol 2008; 128: 876-880.
63. Pullens B, van Benthem PP. Intratympanic gentamicin for Meniere's disease or syndrome. Cochrane Database Syst Rev 2011; CD008234.
64. Garduno-Anaya MA, Couthino De TH, Hinojosa-Gonzalez R, et al. Dexa-methasone inner ear perfusion by intratympanic injection in unilateral Me-niere's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 2005; 133:285-294.
65. Phillips JS, Westerberg B. Intratympanic steroids for Meniere's disease or syndrome. Cochrane Database Syst Rev 2011; CD008514.
66. Casani AP, Piaggi P, Cerchiai N, et al. Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg 2012; 146:430-437.
67. Strupp M, Hupert D, Frenzel C, et al. Long-term prophylactic treatment of attacks of vertigo in Meniere's disease-comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol 2008; 128:520-524.
68. Lezius F, Adrion C, Mansmann U, et al. High-dosage betahistine dihydrochlor-ide between 288 and 480 mg/dayinpatients with severe Meniere's disease: a case series. Eur Arch Otorhinolaryngol 2011; 268:1237-1240.
69. Ihler F, Bertlich M, Sharaf K, et al. Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in Guinea pigs in vivo. PLoS One 2012; 7:e39086.
70. Strupp M, Cnyrim C, Brandt T. Vertigo and dizziness: treatment of benign paroxysmal positioning vertigo, vestibular neuritis and Meniè re's disease. In: Candelise L, editor. Evidence-based neurology-management of neurological disorders. Oxford: Blackwell Publishing; 2007. pp. 59-69.
71. Brandt T, Dieterich M. Vestibular paroxysmia: vascular compression of the eighth nerve? Lancet 1994; 343:798-799.
72. Hufner K, Barresi D, Glaser M, et al. Vestibular paroxysmia: diagnostic features and medical treatment. Neurology 2008; 71:1006-1014.
73. Peker S, Dincer A, Necmettin PM. Vascular compression of the trigeminal nerve is a frequent finding in asymptomatic individuals: 3-T MR imaging of 200 trigeminal nerves using 3D CISS sequences. Acta Neurochir (Wien) 2009; 151:1081-1088.
74. Leal PR, Roch JA, Hermier M, et al. Structural abnormalities of the trigeminal root revealed by diffusion tensor imaging in patients with trigeminal neuralgia caused by neurovascular compression: a prospective, double-blind, controlled study. Pain 2011; 152:2357-2364.
75. Zakrzewska JM, McMillan R. Trigeminal neuralgia: the diagnosis and management of this excruciating and poorly understood facial pain. Postgrad Med J 2011; 87:410-416.
76. Wang QP, Bai M. Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia: a meta-analysis. CNS Drugs 2011; 25:847-857.
77. Yang M, Zhou M, He L, et al. Nonantiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev 2011; CD004029.
78. Russell D, Baloh RW. Gabapentin responsive audiovestibular paroxysmia. J Neurol Sci 2009; 281:99-100.
79. Pollock BE. Surgical management of medically refractory trigeminal neuralgia. Curr Neurol Neurosci Rep 2012; 12:125-131.
80. Zakrzewska JM, Akram H. Neurosurgical interventions for the treatment of classical trigeminal neuralgia. Cochrane Database Syst Rev 2011; CD007312.
81. Jannetta PJ, Moller MB, Moller AR. Disabling positional vertigo. N Engl J Med 1984; 310:1700-1705.
82. Strupp M, Stuckrad-Barre S, Brandt T, Tonn JC. Compression of the eighth cranial nerve causes vestibular paroxysmia. Neurology (in press).
83. Truini A, Barbanti P, Pozzilli C, Cruccu G. A mechanism-based classification of pain in multiple sclerosis. J Neurol 2012. [Epub ahead of print]
84. Marcel C, Anheim M, Flamand-Rouviere C, et al. Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases. J Neurol 2010; 257:1369-1372.
85. Li Y, Zeng C, Luo T. Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings. J Neurol 2011; 258:273-276.
86. Shiiba K, Shindo S, Ikezono T, et al. Cochlin expression in the rat perilymph during postnatal development. Acta Otolaryngol 2012; 132:1134-1139.
87. Bachmann-Harildstad G, Stenklev NC, Myrvoll E, et al. Beta-trace protein as a diagnostic marker for perilymphatic fluid fistula: a prospective controlled pilot study to test a sample collection technique. Otol Neurotol 2011; 32:7-10.
88. Chien WW, Carey JP, Minor LB. Canal dehiscence. Curr Opin Neurol 2011; 24:25-31.
89. Sequeira SM, Whiting BR, Shimony JS, et al. Accuracy of computed tomography detection of superior canal dehiscence. Otol Neurotol 2011; 32:1500-1505.
90. Thabet EM, Abdelkhalek A, Zaghloul H. Superior semicircular canal dehiscence syndrome as assessed by oVEMP and temporal bone computed tomography imaging. Eur Arch Otorhinolaryngol 2012; 269: 1545-1549.
91. Niesten ME, McKenna MJ, Herrmann BS, et al. Utility of cVEMPs in bilateral superior canal dehiscence syndrome. Laryngoscope 2012. [Epub ahead of print]
92. Chien WW, Janky K, Minor LB, Carey JP. Superior canal dehiscence size: multivariate assessment of clinical impact. Otol Neurotol 2012; 33: 810-815.
93. Ward BK, Agrawal Y, Nguyen E, et al. Hearing outcomes after surgical plugging of the superior semicircular canal by a middle cranial fossa approach. Otol Neurotol 2012; 33:1386-1391.
94. Janky KL, Zuniga MG, Carey JP, Schubert M. Balance dysfunction and recovery after surgery for superior canal dehiscence syndrome. Arch Otolar-yngol Head Neck Surg 2012; 138:723-730.
95. Agrawal Y, Minor LB, Schubert MC, et al. Second-side surgery in superior canal dehiscence syndrome. Otol Neurotol 2012; 33:72-77.
96. Lee GS, Zhou G, Poe D, et al. Clinical experience in diagnosis and management of superior semicircular canal dehiscence in children. Laryngoscope 2011; 121:2256-2261.